InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $172.675 0.255 (0.15%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17,978 PME Full year results 22 Aug 2019 9:38AM $26.330 $172.090 risen by 553.59%
$17,978 Full Year Statutory Accounts 22 Aug 2019 9:37AM $26.330 $172.090 risen by 553.59%
$17,978 Preliminary Final Report 22 Aug 2019 9:36AM $26.330 $172.090 risen by 553.59%
$17,978 PME Results release date 19 Aug 2019 5:00PM $27.140 $172.090 risen by 534.08%
$17,978 ZSP:DuluxGroup Limited to be removed from S&P/ASX Indices 31 Jul 2019 4:58PM $30.750 $172.090 risen by 459.64%
$17,978 S&P DJI Announces June 2019 Quarterly Rebalance 14 Jun 2019 8:20AM $23.140 $172.090 risen by 643.69%
$17,978 Investor Presentation - Macquarie Conference 2 May 2019 1:16PM $19.500 $172.090 risen by 782.51%
$17,978 PME signs $14M - 7 year contract with Duke Health 24 Apr 2019 9:24AM $17.850 $172.090 risen by 864.09%
$17,978 On market share buy-back 2 Apr 2019 9:45AM $14.900 $172.090 risen by 1,054.97%
$17,978 HY2019 Investor Presentation - March 2019 18 Mar 2019 9:04AM $16.400 $172.090 risen by 949.33%
$17,978 Dividend/Distribution - PME 22 Feb 2019 12:19PM $14.340 $172.090 risen by 1,100.07%
$17,978 PME - date correction 21 Feb 2019 10:09AM $13.950 $172.090 risen by 1,133.62%
$17,978 Open Briefing - CEO on HY19 results 21 Feb 2019 9:53AM $13.950 $172.090 risen by 1,133.62%
$17,978 Dividend/Distribution - PME 21 Feb 2019 9:23AM $13.950 $172.090 risen by 1,133.62%
$17,978 Company Announcement - Interim Results 21 Feb 2019 9:19AM $13.950 $172.090 risen by 1,133.62%
$17,978 Half Year Accounts 21 Feb 2019 9:18AM $13.950 $172.090 risen by 1,133.62%
$17,978 Appendix 4D 21 Feb 2019 9:16AM $13.950 $172.090 risen by 1,133.62%
$17,978 PME signs new deal with German Government Hospital 10 Dec 2018 9:45AM $10.570 $172.090 risen by 1,528.10%
$17,978 Results of AGM - 2018 20 Nov 2018 12:22PM $9.560 $172.090 risen by 1,700.10%
$17,978 AGM Presentation 2018 20 Nov 2018 10:05AM $9.560 $172.090 risen by 1,700.10%
$17,978 PME signs $27M - 7 year contract with Partners Healthcare 20 Nov 2018 9:55AM $9.560 $172.090 risen by 1,700.10%
$17,978 Annual Report 2018 19 Oct 2018 8:25AM $9.950 $172.090 risen by 1,629.55%
$17,978 Annual General Meeting Proxy Form 19 Oct 2018 8:24AM $9.950 $172.090 risen by 1,629.55%
$17,978 Notice of Annual General Meeting 19 Oct 2018 8:24AM $9.950 $172.090 risen by 1,629.55%
$17,978 FY18 Investor Presentation 3 Sep 2018 9:56AM $10.190 $172.090 risen by 1,588.81%

426 - 450 of 679 results

Page 18 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.